Personal Genome Project (PGP) • Harvard Medical School IRB Human Subjects protocol Approved Aug-2005. • Highly-informed individuals consenting to potentially non-anonymous genomes & extensive phenotypes (medical records, imaging, omics). Volunteer waiting list ** http://pgen.us ** • Cell lines in Coriell NIGMS Repository (B-cells, keratinocytes, fibroblasts) G M Church GM (2005) The Personal Genome Project Nature Molecular Systems Biology doi:10.1038/msb4100040 Kohane IS, Altman RB. (2005) Health-information altruists--a
13
Embed
Personal Genome Project (PGP) Harvard Medical School IRB Human Subjects protocol Approved Aug-2005. Highly-informed individuals consenting to potentially.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Personal Genome Project (PGP)
• Harvard Medical School IRB Human Subjects protocol Approved Aug-2005.
• Cell lines in Coriell NIGMS Repository (B-cells, keratinocytes, fibroblasts)
G M Church GM (2005) The Personal Genome ProjectNature Molecular Systems Biology doi:10.1038/msb4100040 Kohane IS, Altman RB. (2005) Health-information altruists--a potentially critical resource. N Engl J Med. 353:2074-7. McGuire AL, Gibbs RA (2006). Genetics. No longer de-identified. Science. 312:370-1.
International HapMap Project, reconsent form:“It will be very hard for anyone to learn anything about you personally from any of this research because none of the samples, the database, or the HapMap will include your name or any other information that could identify you or your family.”
Genome Wide Association Studies: The proposed GWAS Policy calls for investigators funded by the NIH for GWAS 1) to submit de-identified genotypic and phenotypic data to a centralized NIH repository; and, 2) to submit documentation that describes how the investigators will protect privacy and confidentiality of research participants.
Problems with Status quo “de-identification”
1) Less integrated, holistic, comprehensive
2) Less enabling of system-wide medicine
3) Subjects not informed enough to “opt-out”
4) Life-saving info can’t be shared with subjects
5) False sense of anonymity (next slide)
Is “de-identification” realistic? 1) Re-identification after “de-identification” using other public data. Group Insurance Commission list of birth date, gender, and zip code was sufficient to re-identify medical records of Governor Weld & family via voter-registration records (1998) (2) Hacking. “Drug Records, Confidential Data vulnerable via Harvard ID number & PharmaCare loophole” (2005). A hacker gained access to confidential medical info at the U. Washington Medical Center -- 4000 files (names, conditions, etc, 2000)(3) Combination of surnames from genotype with geographical infoAn anonymous sperm donor was traced on the internet 2005 by his 15 year old son who used his own Y chromosome genealogy to access surname relations. (4) Inferring phenotype from genotype Markers for eye, skin, and hair color, height, weight, racial features, dysmorphologies, etc. are known & the list is growing.(5) Unexpected self-identification. An example of this at Celera undermined confidence in the investigators. Kennedy D. Science. 2002 297:1237. Not wicked, perhaps, but tacky.(6) A tiny amount of DNA data in the public domain with a name leverages the rest. This would allow the vast amount of DNA data in the HapMap (or other study) to be identified. This can happen for example in court cases even if the suspect is acquitted.(7) 26 million Veterans’ medical records including SSN and disabilities stolen Jun 2006.(8) Unauthorized access to DNA bearing samples (9) Identification by phenotype. If CT or MR imaging data is part of a study, one could reconstruct a person’s appearance .
Ethical, Legal Social (ELSI) Advisors Misha Angrist Duke Inst. Genome Sciences & Policy Terry Bard HMS IRB, BIDMC ChaplainDan Brock Harvard Program in Ethics & HealthRuth Chadwick CESAGen, Cardiff Univ. Mildred Cho Stanford EthicsRobert Cook-Deegan Duke Center for Genome Ethics, Law, & PolicyLisa Geller Wilmer-Hale IP Dept. Eric Juengst CWRU Center for Biomedical EthicsJeantine Lunshof EMGO Institute, AmsterdamAmy McGuire Baylor BioethicsPaul Rabinow UC Berkeley AnthropologyJohn Robertson Univ.of Texas School of LawPeter Singer Univ. of Toronto Joint Centre for BioethicsDaniel Vorhaus Harvard Law SchoolLaurie Zoloth Director, Bioethics, Northwestern Univ
‘Next Generation’ Sequencing Status
Multi-molecule Reaction Volume AB/APG Ligase beads 1 fL 454/Roche Pol beads 100,000 fL Solexa Pol term 1 fLCGI Ligase 1 fLAffymetrix Hybr array 100 fL
Single molecules Helicos Biosci Pol <1fLVisigen Biotech Pol FRET <1fLPacific Biosci Pol <1fLAgilent Nanopores <1fL
fL =1E-15 liters(femto)
Next generation sequencing: PoloniesBeads or not, Ligase or Polymerase